HomeALLR • NASDAQ
Allarity Therapeutics Inc
add
$0.80
8.11%
After Hours:(1.33%)+0.011
$0.81
Closed: Jun 5, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.04M | -28.40% |
Net income | -2.73M | 28.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.03M | 28.62% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.20M | 7,977.24% |
Total assets | 29.73M | 148.39% |
Total liabilities | 11.06M | -40.02% |
Total equity | 18.67M | — |
Shares outstanding | 15.08M | — |
Price to book | 0.79 | — |
Return on assets | -28.98% | — |
Return on capital | -45.73% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.73M | 28.91% |
Cash from operations | -2.69M | -91.99% |
Cash from investing | — | — |
Cash from financing | 11.14M | 707.46% |
Net change in cash | 8.17M | 5,496.58% |
Free cash flow | -3.06M | -480.75% |
Previous close
$0.87
Day range
$0.78 - $0.86
Year range
$0.61 - $17.70
Market cap
12.12M USD
Avg Volume
803.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Headquarters
Website
Employees
6
